Table 1 The demographic and clinical characteristics of the patients by quartiles of baseline AIP
Variablea | AIP Quartiles | P value | |||
|---|---|---|---|---|---|
Q1(< − 0.32) | Q2(− 0.32 to < − 0.10) | Q3(− 0.10 to < 0.12) | Q4(≥ 0.12) | ||
Participants | 2522 | 2524 | 2528 | 2525 | |
Males, N (%) | 916 (36.32%) | 1123 (44.49%) | 1292 (51.11%) | 1582 (62.65%) | < 0.001 |
Age,year | 45.28 ± 19.34 | 47.96 ± 18.91 | 50.70 ± 18.13 | 50.11 ± 16.69 | < 0.001 |
BMI, kg/m2 | 26.33 ± 6.57 | 28.31 ± 6.91 | 30.18 ± 7.05 | 31.61 ± 6.83 | < 0.001 |
Race | < 0.001 | ||||
Non-Hispanic White, N (%) | 858 (34.02%) | 900 (35.66%) | 948 (37.50%) | 1084 (42.93%) | |
Non-Hispanic Black, N (%) | 821 (32.55%) | 640 (25.36%) | 437 (17.29%) | 276 (10.93%) | |
Mexican American, N (%) | 216 (8.56%) | 329 (13.03%) | 405 (16.02%) | 447 (17.70%) | |
Other Hispanic, N (%) | 195 (7.73%) | 244 (9.67%) | 314 (12.42%) | 319 (12.63%) | |
Other races, N (%) | 432 (17.13%) | 411 (16.28%) | 424 (16.77%) | 399 (15.80%) | |
Current smoking, N (%) | 508 (20.46%) | 528 (21.26%) | 602 (24.16%) | 678 (27.06%) | < 0.001 |
alcohol intake,drinks per day | < 0.001 | ||||
< 3 | 1124 (69.25%) | 1019 (65.74%) | 939 (61.41%) | 907 (59.17%) | |
≥ 3 | 499 (30.75%) | 531 (34.26%) | 590 (38.59%) | 626 (40.83%) | |
SBP, mmHg | 120.27 ± 18.54 | 122.95 ± 19.13 | 125.28 ± 18.91 | 125.81 ± 17.55 | < 0.001 |
DBP, mmHg | 68.21 ± 11.32 | 68.94 ± 12.06 | 70.29 ± 11.72 | 71.90 ± 12.01 | < 0.001 |
Poverty income ratio | 2.58 ± 1.67 | 2.47 ± 1.64 | 2.40 ± 1.63 | 2.32 ± 1.57 | < 0.001 |
TC, mg/dL | 179.59 ± 37.78 | 183.15 ± 37.80 | 188.26 ± 41.93 | 201.16 ± 45.18 | < 0.001 |
TG, mg/dL | 51.00 (41.00–61.00) | 79.00 (68.00–92.00) | 112.00 (98.00–129.00) | 187.00 (154.00–244.00) | < 0.001 |
eGFR, mL/min/1.73 m2 | 101.11 ± 24.31 | 96.83 ± 24.26 | 93.95 ± 24.08 | 92.71 ± 24.15 | < 0.001 |
Glucose metabolism state | < 0.001 | ||||
none prediabetes | 1398 (55.43%) | 1100 (43.58%) | 811 (32.08%) | 573 (22.69%) | |
prediabetes | 865 (34.30%) | 1021 (40.45%) | 1077 (42.60%) | 1101 (43.60%) | |
diabetes | 259 (10.27%) | 403 (15.97%) | 640 (25.32%) | 851 (33.70%) | |
Antihypertensive drugs | 104 (4.12%) | 144 (5.71%) | 171 (6.76%) | 166 (6.57%) | < 0.001 |
Lipoprotein-lowering drugs | 352 (13.96%) | 497 (19.69%) | 624 (24.68%) | 660 (26.14%) | < 0.001 |